康臣药业集团有限公司（股票代码：01681）于2026年5月22日发布翌日披露报表，宣布在香港联交所场内回购普通股192,000股，占该回购前已发行股本约0.0228%。本次回购每股价格区间介乎每股14.36港元至14.49港元，平均回购价约每股14.4386港元，总金额约277.22万港元。回购的股份将作为库藏股份持有。
公告显示，本次回购完成后，公司于2026年5月22日的已发行股本为841,203,111股，库藏股份数增至344,000股。根据2025年5月22日获通过的股份购回授权，康臣药业可回购的股份总数为85,126,334股，此前已累计回购14,024,000股，占授权总数约16.4743%。公司确认已遵守香港联交所上市规则及相关法律规定。
公告由公司秘书高海恩签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.